Nicholas Latimer

基本信息

浏览量：51

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 152 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Perils of Randomized Controlled Trial Survival Extrapolation Assuming Treatment Effect Waning: Why the Distinction Between Marginal and Conditional Estimates Matters

Angus C. Jennings,Mark J. Rutherford,Nicholas R. Latimer,Michael J. Sweeting,Paul C. Lambert

VALUE IN HEALTHno. 3 (2024): 347-355

引用0浏览0WOS引用

Modeling the Multi-State Natural History of Rare Diseases with Heterogeneous Individual Patient Data: A Simulation Study

Jonathan Broomfield,Keith R. Abrams,Suzanne Freeman,Nicholas Latimer,Mark J. Rutherford,Michael J. Crowther

STATISTICS IN MEDICINE（2024）

引用0浏览0WOS引用

MPES-R: Multi-Parameter Evidence Synthesis in R for Survival Extrapolation—A Tutorial

Ash Bullement,Mark Edmondson-Jones,Patricia Guyot,Nicky J. Welton,Gianluca Baio,Matthew Stevenson,Nicholas R. Latimer

PharmacoEconomicspp.1-11, (2024)

引用0浏览0WOS引用

An Evaluation of an Algorithm for the Selection of Flexible Survival Models for Cancer Immunotherapies: Pass or Fail

Nicholas R. Latimer,Kurt Taylor,Anthony J. Hatswell, Sophia Ho, Gabriel Okorogheye,Clara Chen,Inkyu Kim,John Borrill,David Bertwistle

PHARMACOECONOMICS (2024)

引用0浏览0WOS引用

Treatment Effect Waning in Immuno-oncology Health Technology Assessments: A Review of Assumptions and Supporting Evidence with Proposals to Guide Modelling

Kurt Taylor,Nicholas R. Latimer, Thomas Douglas,Anthony J. Hatswell, Sophia Ho,Gabriel Okorogheye,John Borril,Clara Chen,Inkyu Kim,David Bertwistle

PharmacoEconomicsno. 11 (2024): 1181-1196

引用0浏览0WOS引用

Mixture and Non-mixture Cure Models for Health Technology Assessment: What You Need to Know

Nicholas R. Latimer,Mark J. Rutherford

PHARMACOECONOMICSno. 10 (2024): 1073-1090

引用0浏览0WOS引用

Challenges and Opportunities in Interdisciplinary Research and Real-World Data for Treatment Sequences in Health Technology Assessments

Jen-Yu Amy Chang,James Chilcott,Nicholas R. Latimer

PharmacoEconomics (2024)

引用0浏览0引用

Challenges and Opportunities in Interdisciplinary Research and Real-World Data for Treatment Sequences in Health Technology Assessments

Jen-Yu Amy Chang,James B. Chilcott,Nicholas R. Latimer

PharmacoEconomicsno. 5 (2024): 1-20

引用0浏览0WOS引用

The Feasibility and Acceptability of an App‐based Intervention with Brief Behavioural Support (APPROACH) to Promote Brisk Walking in People Diagnosed with Breast, Prostate and Colorectal Cancer in the UK

Phillippa Lally,Fiona Kennedy, Susan Smith,Rebecca J. Beeken,Caroline Buck,Chloe Thomas,Nicholas Counsell,Lynda Wyld,Charlene Martin, Sarah Williams,Anna Roberts,Diana M. Greenfield,

CANCER MEDICINEno. 6 (2024)

引用0浏览0WOS引用

Transporting Comparative Effectiveness Evidence Between Countries: Considerations for Health Technology Assessments

Alex J. Turner,Cormac Sammon,Nick Latimer,Blythe Adamson,Brennan Beal,Vivek Subbiah,Keith R. Abrams,Joshua Ray

PHARMACOECONOMICSno. 2 (2024): 165-176

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

教授

论文共 152 篇作者统计合作学者相似作者